Literature DB >> 4319621

Polymyxin sensitivity of Candida tropicalis.

M W Nicholls.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4319621     DOI： 10.1099/00222615-3-3-529

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  11 in total

1.  Inhibition of Coccidioides immitis in vitro and enhancement of antiococcidiodial effects of amphotericin B by polymyxin B.

Authors:  S Collins; D Pappagians
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

2.  Time-kill assay and Etest evaluation for synergy with polymyxin B and fluconazole against Candida glabrata.

Authors:  George Pankey; Deborah Ashcraft; Heather Kahn; Abdulrahim Ismail
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

3.  Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect.

Authors:  Bing Zhai; Henry Zhou; Liangpeng Yang; Jun Zhang; Kathy Jung; Chou-Zen Giam; Xin Xiang; Xiaorong Lin
Journal:  J Antimicrob Chemother       Date:  2010-02-18       Impact factor: 5.790

4.  Antifungal properties of polymyxin B and its potentiation of tetracycline as an antifungal agent.

Authors:  S N Schwartz; G Medoff; G S Kobayashi; C N Kwan; D Schlessinger
Journal:  Antimicrob Agents Chemother       Date:  1972-07       Impact factor: 5.191

5.  Enhanced efficacy of synergistic combinations of antimicrobial peptides with caspofungin versus Candida albicans in insect and murine models of systemic infection.

Authors:  D M MacCallum; A P Desbois; P J Coote
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-10       Impact factor: 3.267

6.  The effect of minocycline on Candida albicans.

Authors:  P M Waterworth
Journal:  J Clin Pathol       Date:  1974-04       Impact factor: 3.411

7.  A stability study of amphotericin B, colistin and tobramycin in a hydrophilic suspension commonly used for selective decontamination of the digestive tract by HPLC and in vitro potency measurements.

Authors:  Corina Pfeifer; Sylvia Noll; Hagen Gerecke; Georg Fassauer; Thomas Jira; Yvonne Remane; Jan Vogel; Roberto Frontini; Robert Reinhardt
Journal:  Eur J Hosp Pharm       Date:  2016-08-05

8.  Polymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans-Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy.

Authors:  Maria E Rodrigues; Susana P Lopes; Cláudia R Pereira; Nuno F Azevedo; Anália Lourenço; Mariana Henriques; Maria O Pereira
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

9.  In vitro polymyxin activity against clinical multidrug-resistant fungi.

Authors:  Hanane Yousfi; Stéphane Ranque; Jean-Marc Rolain; Fadi Bittar
Journal:  Antimicrob Resist Infect Control       Date:  2019-04-24       Impact factor: 4.887

10.  Antibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus's egg?

Authors:  Mariska Muijsers; An Martel; Pascale Van Rooij; Kris Baert; Griet Vercauteren; Richard Ducatelle; Patrick De Backer; Francis Vercammen; Freddy Haesebrouck; Frank Pasmans
Journal:  BMC Vet Res       Date:  2012-09-25       Impact factor: 2.741
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.